Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1648 of 5804
-
Can two old drugs save heart failure patients?
Disease control CompletedThe present study is testing in a combined design to types of drugs in patients with chronic heart failure: 1) Hydralazine in combination with isosorbide dinitrate (BiDil) and 2) Metformin hydrochloride. The study is double blind, placebo controlled. 1. The first hypothesis is t…
Phase: PHASE4 • Sponsor: Henrik Wiggers • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Brain cancer vaccine trial combines custom peptides with electric fields
Disease control OngoingThe purpose of this study is to use precision medicine in the form of a vaccine, a mutation-derived tumor antigen vaccine (MTA-based vaccine) in combination with standard care treatment of glioblastoma (GBM) and Tumor Treating Fields (TTFields). The study is designed to determin…
Phase: PHASE1 • Sponsor: Adilia Hormigo • Aim: Disease control
Last updated Jun 26, 2026 15:26 UTC
-
Experimental antibody APX005M takes on childhood brain cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of APX005M in treating younger patients with primary malignant central nervous system tumor that is growing, spreading, or getting worse (progressive), or newly diagnosed diffuse intrinsic pontine glioma. APX005M can trigg…
Phase: PHASE1 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hookworm vaccine shows promise in early human trial
⭐️ VACCINE ⭐️ CompletedThis study evaluates the efficacy, safety and immunogenicity of different formulations of the Na-GST-1 hookworm vaccine using a controlled human hookworm infection model in healthy, hookworm-naive adults.
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
Can diet and exercise boost a psoriasis Drug's power?
Disease control CompletedThis study was a randomized, open-label, parallel-group, active comparator controlled study with two treatment arms designed to answer the question whether the combination of Secukinumab with lifestyle intervention could primarily improve skin symptoms and secondly cardiometaboli…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Robots in the OR: 16,000-Patient trial aims to settle safety and cost questions
Disease control Recruiting nowRobotic minimally invasive surgery has been rapidly adopted for a wide variety of surgical procedures in adult patients across a broad spectrum of surgical specialties. This has occurred despite the high costs and uncertain benefits of surgical robots. In contrast, Children's Ho…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for newborn seizures: levetiracetam tested as First-Line treatment
Disease control CompletedLEVNEONAT is a multicentre French clinical trials with the aim to develop new treatment strategies for the treatment of neonatal seizures using Levetiracetam. The purpose of this study is to determine the correct dosing, safety and efficacy for intravenous levetiracetam as first …
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Boosting radiation for prostate cancer: a safer cure?
Disease control Recruiting nowThe purpose of this research study is to learn more about the outcomes and early and late side effects of treating early stage prostate cancer with high dose rate brachytherapy.
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for kids with tough brain tumors: experimental drug shows promise in early trial
Disease control CompletedThis research study is studying a drug Tovorafenib/DAY101 (formerly TAK-580, MLN2480) as a possible treatment a low-grade glioma that has not responded to other treatments. The name of the study drug involved in this study is: • Tovorafenib/DAY101 (formerly TAK-580, MLN2480)
Phase: PHASE1 • Sponsor: Karen D. Wright, MD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New heart valve shows promise for High-Risk patients
Disease control CompletedProspective, single-arm, multi-center, interventional post-market study. After signing informed consent, eligible subjects will be implanted with the CE marked Evolut™ PRO system. The investigation purpose is to evaluate the acute and long term clinical performance and safety of…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 26, 2026 14:57 UTC
-
Supercharged immune cells take on relapsed leukemia
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of CD4+ and CD8+ HA-1 T cell receptor (TCR) (HA-1 T TCR) T cells in treating patients with acute leukemia that persists, has come back (recurrent) or does not respond to treatment (refractory) following donor stem cell tra…
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Timing is everything: study tests best delivery week for gastroschisis babies
Disease control Recruiting nowThe objective of this study is to investigate the hypothesis that delivery at 35 0/7- 35 6/7 weeks in stable patients with gastroschisis is superior to observation and expectant management with a goal of delivery at 38 0/7 - 38 6/7 weeks. To test this hypothesis, we will complete…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can a botox shot ease Writer's cramp? new trial tests xeomin
Symptom relief Recruiting nowThis study is a multicenter, double-blind, randomized placebo controlled, parallel group, superiority trial in order to test the superiority of intramuscular injections of IncobotulinumtoxinA against placebo using a 1:1 allocation ratio.
Phase: PHASE3 • Sponsor: Alain Kaelin • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Heart drug shows promise for liver health in kids with rare heart condition
Disease control CompletedA study to evaluate the efficacy of MZ101 therapy in reducing liver stiffness.
Phase: PHASE3 • Sponsor: Mezzion Pharma Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Aspirin vs. heparin: which prevents clots better after cancer bone surgery?
Disease control ENROLLING_BY_INVITATIONAspirin and low molecular weight heparin (LMWH) are both commonly employed pharmacologic methods of venous thromboembolism (VTE) prophylaxis after orthopaedic surgery. Data comparing these two methods of VTE prophylaxis in patients undergoing pelvic/lower extremity orthopaedic su…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for autoimmune hepatitis patients who fail standard treatment
Disease control CompletedVAY736 dose testing; VAY736 efficacy and safety testing.
Phase: PHASE2, PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental drug combo targets Hard-to-Treat sarcomas
Disease control CompletedThe objective of this study is to assess the safety and efficacy of mecbotamab vedotin (BA3011) in solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: BioAtla, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Lab tests could pick the right drug for tough myeloma cases
Knowledge-focused OngoingThis pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or plasma cell leukemia that has come back or does not respond to treatment. High throughput scr…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New heart scan could catch damage early in childhood cancer survivors
Knowledge-focused Recruiting nowThis multicenter, prospective cohort study evaluates early cardiac dysfunction in adult survivors of childhood cancer. The hypothesis of this study is that cardiac dysfunction can be detected earlier when using speckle tracking echocardiography as novel echocardiographic techniqu…
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise in blocking kaposi sarcoma growth
Disease control CompletedThis phase II trial studies recombinant EphB4-HSA fusion protein (EphB4-HSA) in treating patients with Kaposi sarcoma. Recombinant EphB4-HSA fusion protein may block the growth of blood vessels that provide blood to the cancer, and may also prevent cancer cells from growing.
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC